Drug Trial Radar · NCT06930859
Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia
Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
2,766
Planned (sponsor's estimate)
Start
Dec 3, 2025
Primary completion
Dec 31, 2032
Study completion Dec 31, 2032
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Apr 16, 2025
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This prospective, observational, multicenter study aims at evaluating the efficacy of adjuvant ribociclib in combination with hormone therapy (aromatase inhibitor ± GnRH aginost) in various subgroups of patients with HR+HER2- stage II-III breast cancer in real clinical practice in Russia. Subgroup division will be based on the tumor grade, lymph node involvement, and the response to test hormone therapy. The study will consist of two cohorts: a prospective one with patients receiving adjuvant therapy with ribociclib combined with Aromatase inhibitors (AI), and a retrospective one with patients receiving adjuvant therapy with AI alone. Thus, both primary data collection and secondary use of data will be organized.
Conditions
- Breast Cancer
Interventions
RibociclibDrug
CDK4/6 inhibitor
LetrozoleDrug
Aromatase inhibitor
AnastrozoleDrug
Aromatase inhibitor
Primary outcomes
What the sponsor says the trial is designed to measure.
- Invasive breast cancer-free survival (IBCFS) according to the Standardized Definitions for Efficacy End Points (STEEP) criteria in a prospective cohortTime frame: Months 36, 48, 60
Locations
49 sites in 1 country. Site status is shown where the registry gives one.
Novartis Investigative Site
Arkhangelsk, Russia · Recruiting
Novartis Investigative Site
Barnaul, Russia · Recruiting
Novartis Investigative Site
Bryansk, Russia · Recruiting
Novartis Investigative Site
Chelyabinsk, Russia · Recruiting
Novartis Investigative Site
Irkutsk, Russia · Recruiting
Novartis Investigative Site
Ivanovo, Russia · Recruiting
Novartis Investigative Site
Izhevsk, Russia · Recruiting
Novartis Investigative Site
Kemerovo, Russia · Recruiting
Novartis Investigative Site
Khabarovsk, Russia · Recruiting
Novartis Investigative Site
Khanty-Mansiysk, Russia · Recruiting
Novartis Investigative Site
Khimky, Russia · Recruiting
Novartis Investigative Site
Kirov, Russia · Recruiting
Novartis Investigative Site
Krasnodar, Russia · Recruiting
Novartis Investigative Site
Krasnoyarsk, Russia · Recruiting
Novartis Investigative Site
Lipetsk, Russia · Recruiting
Novartis Investigative Site
Moscow, Russia · Recruiting
Novartis Investigative Site
Moscow, Russia · Recruiting
Novartis Investigative Site
Moscow, Russia · Recruiting
Novartis Investigative Site
Moscow, Russia · Recruiting
Novartis Investigative Site
Moscow Region Balas, Russia · Recruiting
Novartis Investigative Site
Perm, Russia · Recruiting
Novartis Investigative Site
Pyatigorsk, Russia · Recruiting
Novartis Investigative Site
Rostov-on-Don, Russia · Recruiting
Novartis Investigative Site
Saint Petersburg, Russia · Recruiting
Novartis Investigative Site
Saint Petersburg, Russia · Recruiting
Novartis Investigative Site
Saint Petersburg, Russia · Recruiting
Novartis Investigative Site
Samara, Russia · Recruiting
Novartis Investigative Site
Saransk, Russia · Recruiting
Novartis Investigative Site
Saratov, Russia · Recruiting
Novartis Investigative Site
Sestroretsk, Russia · Recruiting
Novartis Investigative Site
Shakhty, Russia · Recruiting
Novartis Investigative Site
Tambov, Russia · Recruiting
Novartis Investigative Site
Tomsk, Russia · Recruiting
Novartis Investigative Site
Tver', Russia · Recruiting
Novartis Investigative Site
Tyumen, Russia · Recruiting
Novartis Investigative Site
Ufa, Russia · Recruiting
Novartis Investigative Site
Vladikavkaz, Russia · Recruiting
Novartis Investigative Site
Vladivostok, Russia · Recruiting
Novartis Investigative Site
Volgograd, Russia · Recruiting
Novartis Investigative Site
Voronezh, Russia · Recruiting
Showing 40 of 49 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.